BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28185946)

  • 1. Decreased tacrolimus plasma concentrations during HCV therapy: a drug-drug interaction or is there an alternative explanation?
    Smolders EJ; Pape S; de Kanter CT; van den Berg AP; Drenth JP; Burger DM
    Int J Antimicrob Agents; 2017 Mar; 49(3):379-382. PubMed ID: 28185946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of direct-acting antivirals for hepatitis C virus therapy on tacrolimus dosing in liver transplant recipients.
    Bixby AL; Fitzgerald L; Leek R; Mellinger J; Sharma P; Tischer S
    Transpl Infect Dis; 2019 Jun; 21(3):e13078. PubMed ID: 30884055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications.
    Smolders EJ; de Kanter CT; de Knegt RJ; van der Valk M; Drenth JP; Burger DM
    Clin Pharmacokinet; 2016 Dec; 55(12):1471-1494. PubMed ID: 27317413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers.
    Hulskotte E; Gupta S; Xuan F; van Zutven M; O'Mara E; Feng HP; Wagner J; Butterton J
    Hepatology; 2012 Nov; 56(5):1622-30. PubMed ID: 22576324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting.
    Tischer S; Fontana RJ
    J Hepatol; 2014 Apr; 60(4):872-84. PubMed ID: 24280292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supra-therapeutic tacrolimus concentrations associated with concomitant nicardipine in pediatric liver transplant recipients.
    Hurst AL; Clark N; Carpenter TC; Sundaram SS; Reiter PD
    Pediatr Transplant; 2015 Jun; 19(4):E83-7. PubMed ID: 25850753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV).
    Schvarcz R; Rudbeck G; Söderdahl G; Ståhle L
    Transplantation; 2000 May; 69(10):2194-5. PubMed ID: 10852623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-drug interaction with telaprevir or boceprevir in liver transplant patients: about four cases].
    Delaborde L; Logerot S; Fonrose X
    Therapie; 2014; 69(6):491-7. PubMed ID: 25320939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.
    Antonini TM; Furlan V; Teicher E; Haim-Boukobza S; Sebagh M; Coilly A; Bonhomme-Faivre L; Roque-Afonso AM; Vittecoq D; Samuel D; Taburet AM; Duclos-Vallée JC
    AIDS; 2015 Jan; 29(1):53-8. PubMed ID: 25387314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection.
    Duvoux C; Villamil F; Renner EL; Grazi GL; Firpi RJ; Pageaux G; Mulhaupt B; Schirm F; Rauer B; Bernhardt P; Levy G
    Ann Transplant; 2015 Jan; 20():25-35. PubMed ID: 25588713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors].
    Ruiz Ramos J; Romero Hernández I; Marrero Álvarez P; Marqués Miñana MR; Fernández Megía MJ; Poveda Andrés JL
    Gastroenterol Hepatol; 2014 Dec; 37(10):558-63. PubMed ID: 24951300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus.
    Garg V; van Heeswijk R; Lee JE; Alves K; Nadkarni P; Luo X
    Hepatology; 2011 Jul; 54(1):20-7. PubMed ID: 21618566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
    Charlton M
    Hepatology; 2011 Jul; 54(1):3-5. PubMed ID: 21710471
    [No Abstract]   [Full Text] [Related]  

  • 14. Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions.
    Seden K; Back D
    Curr Opin HIV AIDS; 2011 Nov; 6(6):514-26. PubMed ID: 22001895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus/cerivastatin interaction study in liver transplant recipients.
    Mück W; Neal DA; Boix O; Voith B; Hasan R; Alexander GJ
    Br J Clin Pharmacol; 2001 Aug; 52(2):213-5. PubMed ID: 11488782
    [No Abstract]   [Full Text] [Related]  

  • 16. Oseltamivir, an influenza neuraminidase inhibitor drug, does not affect the steady-state pharmacokinetic characteristics of cyclosporine, mycophenolate, or tacrolimus in adult renal transplant patients.
    Lam H; Jeffery J; Sitar DS; Aoki FY
    Ther Drug Monit; 2011 Dec; 33(6):699-704. PubMed ID: 22105586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
    Kondili LA; Gaeta GB; Ieluzzi D; Zignego AL; Monti M; Gori A; Soria A; Raimondo G; Filomia R; Di Leo A; Iannone A; Massari M; Corsini R; Gulminetti R; Gatti Comini A; Toniutto P; Dissegna D; Russo FP; Zanetto A; Rumi MG; Brancaccio G; Danieli E; Brunetto MR; Weimer LE; Quaranta MG; Vella S; Puoti M
    PLoS One; 2017; 12(2):e0172159. PubMed ID: 28245248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focus on drug interactions: the challenge of treating hepatitis C virus infection with direct-acting antiviral drugs in the HIV-positive patient.
    Rodríguez-Torres M
    Curr Opin Infect Dis; 2013 Feb; 26(1):50-7. PubMed ID: 23242341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation.
    Oellerich M; Schütz E; Kanzow P; Schmitz J; Beck J; Kollmar O; Streit F; Walson PD
    Ther Drug Monit; 2014 Apr; 36(2):136-40. PubMed ID: 24452066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
    Grant JL; Hawkins C; Brooks H; Palella FJ; Koppe SW; Abecassis MM; Stosor V
    AIDS; 2016 Jan; 30(1):93-8. PubMed ID: 26731756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.